Guardant Health Is Acting Like a New Leadership Stock Again
Guardant Health just printed fresh 52-week highs as the market digests another FDA companion diagnostic win. With strong liquidity ratios, bullish technicals, and elevated short interest that can add fuel, GH is set up for a continuation move if buyers defend the breakout area. This trade leans into the idea that revenue growth can surprise to the …